SAKK/BMS Grant «HEM Pioneer»

Many types of blood cancer remain incurable and are associated with severe morbidity and increased mortality. SAKK’s HEM Pioneer Grant is funded by BMS and aims to support projects and research that could potentially pave the way for a game changing outcome in the field of blood cancers. The Grant is endowed with CHF 50,000.

The call for proposal is open now. Your application must be submitted electronically via this webpage. Please send your application until October 13, 2021.

For further details please read the rules and regulations on this website.


  • Application «HEM Pioneer»

    Is the project conducted in Switzerland?
    Is this proposal part of a larger research project/trial?
    Unlimited number of files can be uploaded to this field.
    50 MB limit.
    Allowed types: pdf.

    Please upload your project description using this Word Document 

    One file only.
    200 MB limit.
    Allowed types: txt, doc, docx.
  • Flyer «HEM Pioneer»

  • Rules and Regulation «HEM Pioneer»

  • Competence Center of SAKK
    Effingerstrasse 33
    CH-3008 Bern
    Tel: +41 31 389 91 91
    E-Mail: events@sakk.ch


  • HEM

    The SAKK/Celgene Grant 2020 for pioneering ideas to combat leukemia was awarded to Dr. med. Mattia Rizzi at Lausanne University Hospital (CHUV) for his project, “Prediction of thrombo-hemorrhagic complications in children with acute lymphoblastic leukemia and lymphoblastic lymphoma: the role of novel global hemostasis assays.”


    Press Release SAKK / Celgene “HEM Pioneer Grant” 2019

    HEMProf. Dr. med. Gabriela Baerlocher (Jury President and SAKK Board Member) with Dr. med. Corinne Widmer (University Hospital Zurich)